EA201000810A1 - PHARMACEUTICAL COMPOSITION - Google Patents

PHARMACEUTICAL COMPOSITION

Info

Publication number
EA201000810A1
EA201000810A1 EA201000810A EA201000810A EA201000810A1 EA 201000810 A1 EA201000810 A1 EA 201000810A1 EA 201000810 A EA201000810 A EA 201000810A EA 201000810 A EA201000810 A EA 201000810A EA 201000810 A1 EA201000810 A1 EA 201000810A1
Authority
EA
Eurasian Patent Office
Prior art keywords
sulfate salt
pharmaceutical composition
ibuprofen
excipients
joints
Prior art date
Application number
EA201000810A
Other languages
Russian (ru)
Other versions
EA019542B1 (en
Inventor
Анна Божек
Original Assignee
Байер Конзумер Кэр Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EA200702569A external-priority patent/EA200702569A1/en
Application filed by Байер Конзумер Кэр Аг filed Critical Байер Конзумер Кэр Аг
Priority to EA201000810A priority Critical patent/EA019542B1/en
Publication of EA201000810A1 publication Critical patent/EA201000810A1/en
Publication of EA019542B1 publication Critical patent/EA019542B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Настоящее изобретение относится к области медицины, более конкретно - к лекарственным средствам для внутреннего применения, для лечения болевого синдрома в течение фазы усиления боли при первичном остеоартрозе и вторичном остеоартрозе и других дегенеративно-дистрофических заболеваниях суставов конечностей и межпозвоночных дисков. Фармацевтическая композиция для перорального введения содержит соль хондроитин сульфата и соль глюкозамин сульфата, ибупрофен в качестве нестероидного противовоспалительного средства и вспомогательные вещества, где компоненты содержатся в следующем соотношении, % мас./мас.: соль хондроитин сульфата от 20 до 30, соль глюкозамин сульфата от 30 до 36, ибупрофен от 10 до 15 и вспомогательные вещества в достаточном количестве. Настоящее изобретение относится к фармацевтической композиции, которая обладает хондропротективным, противовоспалительным и обезболивающим действием, к эффективному лечению дегенеративно-дистрофических заболеваний суставов конечностей и межпозвоночных дисков, удобству использования препарата, снижению риска возникновения побочных эффектов и предоставлению альтернативного лекарственного средства.The present invention relates to medicine, more specifically to medicines for internal use, for the treatment of pain during the phase of increased pain in primary osteoarthritis and secondary osteoarthritis and other degenerative diseases of the joints of the limbs and intervertebral discs. The pharmaceutical composition for oral administration contains chondroitin sulfate salt and glucosamine sulfate salt, ibuprofen as a non-steroidal anti-inflammatory drug and excipients, where the components are in the following ratio,% w / w: chondroitin sulfate salt from 20 to 30, glucosamine sulfate salt from 30 to 36, ibuprofen from 10 to 15 and excipients in sufficient quantities. The present invention relates to a pharmaceutical composition that has a chondroprotective, anti-inflammatory and analgesic effect, to the effective treatment of degenerative diseases of the joints of the extremities and intervertebral discs, the convenience of using the drug, reducing the risk of side effects and providing an alternative medication.

EA201000810A 2007-11-23 2008-11-21 A pharmaceutical composition EA019542B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EA201000810A EA019542B1 (en) 2007-11-23 2008-11-21 A pharmaceutical composition

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
UA2007012960 2007-11-23
EA200702569A EA200702569A1 (en) 2007-12-20 2007-12-20 PHARMACEUTICAL COMPOSITION
PCT/EP2008/009897 WO2009065604A2 (en) 2007-11-23 2008-11-21 Pharmaceutical composition comprising glucosamine sulfate, chondroitine sulfate and ibuprofene
EA201000810A EA019542B1 (en) 2007-11-23 2008-11-21 A pharmaceutical composition

Publications (2)

Publication Number Publication Date
EA201000810A1 true EA201000810A1 (en) 2010-12-30
EA019542B1 EA019542B1 (en) 2014-04-30

Family

ID=40525286

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201000810A EA019542B1 (en) 2007-11-23 2008-11-21 A pharmaceutical composition

Country Status (2)

Country Link
EA (1) EA019542B1 (en)
WO (1) WO2009065604A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2742172C2 (en) * 2017-06-30 2021-02-02 Общество с ограниченной ответственностью "ФБК" Combination of a chondroprotective agent with an nsaid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003099013A1 (en) * 2000-01-24 2003-12-04 Omni Nutraceuticals, Inc. Acetaminophen/non-steroidal anti-inflamatory drug-glucosamine composition
RU2260432C1 (en) * 2004-10-12 2005-09-20 Открытое Акционерное Общество "Нижегородский Химико-Фармацевтический Завод" (Оао "Нижфарм") Agent for treatment of articulation diseases

Also Published As

Publication number Publication date
EA019542B1 (en) 2014-04-30
WO2009065604A3 (en) 2009-10-08
WO2009065604A2 (en) 2009-05-28

Similar Documents

Publication Publication Date Title
RU2470016C2 (en) Bipirazole derivative
WO2007112274A3 (en) Formulations of low dose non-steroidal anti-inflammatory drugs and beta-cyclodextrin
WO2013003629A3 (en) Methods and compositions for inhibition of bone resorption
ES2527344T3 (en) Flurbiprofen and muscle relaxant combinations
EA200870469A1 (en) NEW, CONTAINING NIMESULIDE, PHARMACEUTICAL COMPOSITIONS WITH LOW DOSE, THEIR RECEPTION AND APPLICATION
NZ587202A (en) Methods for measuring a patient response upon administration of a drug and compositions thereof
IL196425A0 (en) Pharmaceutical compositions containing ibuprofen and famotidine
WO2005035485A3 (en) Analgesic compounds, their synthesis and pharmaceutical compositions containing them
EA201492010A1 (en) APPLICATION OF HIGH DOSE OF LACHINIMODE FOR TREATMENT OF MULTIPLE SCLEROSIS
MX2018008021A (en) Methods and compositions for the treatment of seizure-related disorders.
EA200500941A1 (en) MEANS FOR TREATING JOINT DISEASES
AU2009304002B9 (en) A medicinal product and treatment
WO2008008882A3 (en) Glucocorticoid receptor modulator and methods of use
JP2017512194A5 (en)
UA96457C2 (en) Delayed-release glucocorticoid treatment of rheumatoid disease
Rose et al. Comparison of lornoxicam and rofecoxib in patients with activated osteoarthritis (COLOR Study)
EA201000810A1 (en) PHARMACEUTICAL COMPOSITION
EA201400484A1 (en) TRANSDERMAL MEANS FOR THE TREATMENT AND PREVENTION OF DISEASES OF JOINT AND SOFT TISSUES
RU2019102890A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING FLURBIPROPHEN
EA200500942A1 (en) MEANS FOR TREATING JOINT DISEASES
EA201290378A1 (en) COMPOSITIONS CONTAINING NESTEROIDIC ANTI-INFLAMMATORY MEDICINES
UA103309C2 (en) Pharmaceutical composition for oral administration comprises chondroitin sulfate salt and glycosamine sulfate salt, ibuprofen
MX2021003030A (en) Pharmaceutical compositions suitable for articular delivery and use thereof in treatment of joint pain.
CA2798420A1 (en) Combination of an nsaid and an amino acid
EA200702569A1 (en) PHARMACEUTICAL COMPOSITION

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AZ MD TJ TM